InvestSMART

CSL Limited (ASX: CSL) - Announcements

Current share price for CSL : $202.040 1.31 (0.65%)+

ASX company news and announcements for CSL Limited (CSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All CSL Limited (CSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than CSL Limited (CSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for CSL Limited (CSL)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$97,114 Daily share buy-back notice - Appendix 3E 10 Mar 2016 8:49AM $104.700 $202.370 risen by 93.29%
$97,114 Daily share buy-back notice - Revised Appendix 3E 9 Mar 2016 8:45AM $102.430 $202.370 risen by 97.57%
$97,114 Daily share buy-back notice - Appendix 3E 9 Mar 2016 8:26AM $102.430 $202.370 risen by 97.57%
$97,114 Daily share buy-back notice - Appendix 3E 8 Mar 2016 8:43AM $103.150 $202.370 risen by 96.19%
$97,114 IDELVION(R) (rFIX-FP) - FDA approval 7 Mar 2016 9:13AM $102.570 $202.370 risen by 97.30%
$97,114 Daily share buy-back notice - Appendix 3E 7 Mar 2016 9:03AM $102.570 $202.370 risen by 97.30%
$97,114 Daily share buy-back notice - Appendix 3E 4 Mar 2016 8:25AM $104.360 $202.370 risen by 93.92%
$97,114 Daily share buy-back notice - Appendix 3E 3 Mar 2016 8:23AM $105.020 $202.370 risen by 92.70%
$97,114 Daily share buy-back notice - Appendix 3E 2 Mar 2016 8:45AM $103.300 $202.370 risen by 95.91%
$97,114 Daily share buy-back notice - Appendix 3E 1 Mar 2016 8:59AM $102.720 $202.370 risen by 97.01%
$97,114 IDELVION(R) (rFIX-FP) - CHMP recommendation 29 Feb 2016 8:59AM $102.390 $202.370 risen by 97.65%
$97,114 Daily share buy-back notice - Appendix 3E 29 Feb 2016 8:16AM $102.390 $202.370 risen by 97.65%
$97,114 Change of Director's Interest Notice 26 Feb 2016 3:53PM $101.980 $202.370 risen by 98.44%
$97,114 Changes relating to buy-back - Appendix 3D 26 Feb 2016 8:19AM $101.440 $202.370 risen by 99.50%
$97,114 Daily share buy-back notice - Appendix 3E 26 Feb 2016 8:11AM $101.440 $202.370 risen by 99.50%
$97,114 Daily share buy-back notice - Appendix 3E 25 Feb 2016 8:21AM $100.950 $202.370 risen by 100.47%
$97,114 Daily share buy-back notice - Appendix 3E 24 Feb 2016 10:43AM $101.420 $202.370 risen by 99.54%
$97,114 Appendix 3B 23 Feb 2016 3:16PM $101.270 $202.370 risen by 99.83%
$97,114 Daily share buy-back notice - Appendix 3E 23 Feb 2016 9:07AM $102.500 $202.370 risen by 97.43%
$97,114 Daily share buy-back notice - Appendix 3E (Replacement) 22 Feb 2016 8:45AM $101.800 $202.370 risen by 98.79%
$97,114 Daily share buy-back notice - Appendix 3E 22 Feb 2016 8:21AM $101.800 $202.370 risen by 98.79%
$97,114 Change of Director's Interest Notice 19 Feb 2016 2:42PM $101.680 $202.370 risen by 99.03%
$97,114 Daily share buy-back notice - Appendix 3E 19 Feb 2016 8:18AM $100.670 $202.370 risen by 101.02%
$97,114 Daily share buy-back notice - Appendix 3E 18 Feb 2016 8:44AM $102.080 $202.370 risen by 98.25%
$97,114 HY2016 Results Announcement and Analyst Briefing (Correction 17 Feb 2016 8:17AM $106.000 $202.370 risen by 90.92%

976 - 1000 of 1205 results

Page 40 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.